Found 5 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is P and Author is Boron, M  [Clear All Filters]
2003
M. Hudak, Boron, M., Cohen, A., Van Veldhuisen, P., and Group, thePalivizuma, “Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry”, 2003.
S. Cohen, Boron, M., Cohen, A., Van Veldhuisen, P., and Group, thePalivizuma, “Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry”, J Perinatology, vol. 23, p. 594, 2003.
2006
H. X. Chen, Mooney, M., Boron, M., Vena, D., Mosby, K., Grochow, L., Jaffe, C., Rubinstein, L., Zwiebel, J., and Kaplan, R. S., “Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients with Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301”, J Clin Oncol, vol. 24, pp. 3354-3360, 2006.
2008
M. Frogel, Nerwen, C., Boron, M., Cohen, A., Van Veldhuisen, P., Harrington, M., and Group, P. Outcomes R., “Prevention of Hospitalization Due to Respiratory Syncytial Virus: Results from the Palivizumab Outcomes Registry”, J Perinatol, vol. 28, pp. 511-517, 2008.
M. Frogel, Nerwen, C., Cohen, A., VanVeldhuisen, P., Harrington, M., and Boron, M., “Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.”, J Perinatol, vol. 28, no. 7, pp. 511-7, 2008.